POLYPEPTIDE COMBINATION USED FOR TUMOUR IMMUNOTHERAPY, AND PREPARATION METHOD THEREFOR

Provided is a polypeptide combination, a targeting component thereof comprising a shielding peptide, a cleavable part, an antigen-binding part and a first intein fragment, the shielding peptide and the antigen-binding part being connected by means of the cleavable part, and the antigen-binding part...

Full description

Saved in:
Bibliographic Details
Main Authors HAN, Lei, ZONG, Huifang, ZHU, Jianwei, WANG, Jing, XIE, Yueqing, JIANG, Hua, CHEN, Junsheng
Format Patent
LanguageEnglish
French
German
Published 11.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Provided is a polypeptide combination, a targeting component thereof comprising a shielding peptide, a cleavable part, an antigen-binding part and a first intein fragment, the shielding peptide and the antigen-binding part being connected by means of the cleavable part, and the antigen-binding part being directly or indirectly connected to the first intein fragment; a toxin component thereof comprises a second intein fragment and a toxin, and the second intein fragment is directly or indirectly connected to the toxin; the targeting component and the toxin component form an immunoconjugate by means of the interactive action between the first intein fragment and the second intein fragment; in the immunoconjugate, the shielding peptide and the antigen-binding part are connected by means of the cleavable part, and the antigen-binding part is connected to the toxin. Also provided are a preparation method and a pharmaceutical use for the polypeptide combination.
Bibliography:Application Number: EP20200796067